Generic Name and Formulations:
Acyclovir 5% + hydrocortisone 1%; crm.
Bausch Health Companies Inc.
Indications for XERESE:
Early treatment of recurrent herpes labialis (cold sores), to reduce likelihood of ulcerative cold sores and shorten lesion healing time in adults and adolescents (≥12yrs old).
Start as soon as possible after the first signs/symptoms emerge (ie, during the prodrome or when lesions appear). Wash and dry area. Apply topically to affected area on lips or around the mouth 5 times daily for 5 days. Avoid unnecessary rubbing of affected area to avoid aggravating or transferring infection. Do not occlude. Wash hands before and after application; wait at least 30 minutes before bathing, showering, or swimming.
Immunocompromised. Reevaluate if symptoms persist more than 2 weeks. Avoid eyes, inside the mouth or nose, or on the genitals. Pregnancy (Cat. B). Nursing mothers.
Antiviral + antiinflammatory.
Do not apply other products (makeup, sunscreen, lip balm, etc) to area during treatment.
Drying, flaking, burning/tingling sensation, erythema, pigmentation changes.
Neurology Advisor Articles
- Erenumab Superior to Placebo for Reducing Migraine Disability, Improving HRQoL
- Managing Status Epilepticus in Palliative Care: Accounting for Patient and Family Experience
- Congress Passes Bill to Fight Opioid Crisis
- Physical Activity Decreases Vascular Comorbidities in Multiple Sclerosis
- Review of Factors Impacting Sport-Related Concussion Headaches
- Anodal tDCS Offers Possible Benefit for Improving Item Recall in Post-Stroke Aphasia
- Hospitalization Tied to Brain Abnormalities in Older Adults
- Spending Often Persists in High-Cost Medicare-Medicaid Eligible
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure